Author:
Chow Warren A.,Synold Timothy W.,Tetef Merry L.,Longmate Jeffrey,Frankel Paul,Lawrence Joyce,Al-Khadimi Zaid,Leong Lucille,Lim Dean,Margolin Kim,Morgan Robert J.,Raschko James,Shibata Stephen,Somlo George,Twardowski Przemyslaw,Yen Yun,Doroshow James H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference41 articles.
1. Bakowski MT, Prentice HG, Lister TA, Malpas JS, McElwain TJ, Powles RL (1979) Limited activity of ICRF-159 in advanced acute leukemia. Cancer Treat Rep 63:127
2. Bellet RE, Engstrom PF, Catalano RB, Creech RH, Mastrangelo MJ (1976) Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy. Cancer Treat Rep 60:1935
3. Billingham ME, Bristow MR, Glatstein E, Mason JW, Masek MA, Daniels JR (1975) Adriamycin cardiotoxicity: endomyocardial biopsy evidence of enhancement by irradiation. Am J Surg Pathol 1:17
4. Bristow MR, Thompson PD, Martin RP, Mason JW, Billingham ME, Harrison DC (1978) Early anthracycline cardiotoxicity. Am J Med 65:823
5. Bugat R, Robert J, Herrera A, Pinel MC, Huet S, Chevreau C, Boussin G, Roquain J, Carton M (1989) Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patients. Eur J Cancer Clin Oncol 25:505
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献